Andrew J Yee

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Histone Deacetylase

Top Venues

Expert review of hematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew J Yee
Improving outcomes with anti-BCMA bispecific antibodies with attention to infection. Blood cancer journal 14 (1) (2024)
Yuxin Liu, Clifton C Mo, Monique A Hartley-Brown, Adam S Sperling, Shonali Midha, Andrew J Yee, Giada Bianchi, Catherine Piper, Alice Tattersall, Omar Nadeem, Jacob P Laubach, Paul Gerard Richardson
Targeting ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide. Expert review of hematology (2024)
Mary C Boulanger, Marisa G Tieger, Dean Eliott, Andrew J Yee
Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome. EJHaem 5 (2) (2024)
Yuxin Liu, Clifton C Mo, Monique A Hartley-Brown, Adam S Sperling, Shonali Midha, Andrew J Yee, Giada Bianchi, Catherine Piper, Alice Tattersall, Omar Nadeem, Jacob P Laubach, Paul Gerard Richardson
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide. Expert review of hematology 17 (8) (2024)
Andrew J Yee
Improving outcomes with anti-BCMA bispecific antibodies with attention to infection. Blood cancer journal 14 (1) (2024)
Yuxin Liu, Clifton C Mo, Monique A Hartley-Brown, Adam S Sperling, Shonali Midha, Andrew J Yee, Giada Bianchi, Catherine Piper, Alice Tattersall, Omar Nadeem, Jacob P Laubach, Paul Gerard Richardson
Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide. Expert review of hematology (2024)
Andrew J Yee
An ATLAS to map MRD with peripheral blood. Blood 144 (9) (2024)
Andrew J Yee
Improving outcomes with anti-BCMA bispecific antibodies with attention to infection. Blood cancer journal 14 (1) (2024)
Mary C Boulanger, Marisa G Tieger, Dean Eliott, Andrew J Yee
Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome. EJHaem 5 (2) (2024)
Clifton C Mo, Andrew J Yee, Shonali Midha, Monique A Hartley-Brown, Omar Nadeem, Elizabeth K O'Donnell, Giada Bianchi, Adam S Sperling, Jacob P Laubach, Paul Gerard Richardson
Selinexor: Targeting a novel pathway in multiple myeloma. EJHaem 4 (3) (2023)
Gareth Peter Gregory, Shaji K Kumar, Ding Wang, Daruka Mahadevan, Patricia Walker, Nina D Wagner-Johnston, Carolina Escobar, Rajat Bannerji, Divaya Bhutani, Julie Chang, Francisco J Hernandez-Ilizaliturri, Andreas Klein, John M Pagel, Witold B Rybka, Andrew J Yee, Anne Mohrbacher, Mo Huang, Mohammed Farooqui, Patricia Marinello, Hang Quach
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study. Blood advances 6 (4) (2022)
Elizabeth K O' Donnell, Yael N Shapiro, Andrew J Yee, Omar Nadeem, Jacob P Laubach, Andrew R Branagan, Kenneth C Anderson, Clifton C Mo, Nikhil C Munshi, Irene M Ghobrial, Adam S Sperling, Emerentia A Agyemang, Jill N Burke, Cynthia C Harrington, Bonnie Y Hu, Paul G Richardson, Noopur S Raje, Areej El-Jawahri
Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma. Blood advances 6 (17) (2022)
Matthew M Lei, Erica Tavares, Evan Buzgo, Uvette Y Lou, Noopur Raje, Andrew J Yee
Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma. Leukemia & lymphoma (2022)
Andrew J Yee
The role of carfilzomib in relapsed/refractory multiple myeloma. Therapeutic advances in hematology 12 (2021)
Jorge J Castillo, Kirsten Meid, Joshua N Gustine, Carly Leventoff, Timothy White, Catherine A Flynn, Shayna R Sarosiek, Maria G Demos, Maria L Guerrera, Amanda Kofides, Xia Liu, Manit Munshi, Nicholas Tsakmaklis, Lian Xu, Guang Yang, Andrew R Branagan, Elizabeth O'Donnell, Noopur Raje, Andrew J Yee, Christopher J Patterson, Zachary R Hunter, Steven P Treon
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia. Leukemia (2021)
Johannes Moritz Waldschmidt, Jake A Kloeber, Praveen Anand, Julia Frede, Antonis Kokkalis, Valeriya Dimitrova, Sayalee Potdar, Monica S Nair, Tushara Vijaykumar, Nam Gyu Im, Amy Guillaumet-Adkins, Nitish Chopra, Hannah Stuart, Lillian Budano, Noori Sotudeh, Guangwu Guo, Clemens Grassberger, Andrew J Yee, Jacob P Laubach, Paul Gerard Richardson, Kenneth C Anderson, Noopur S Raje, Birgit Knoechel, Jens G Lohr
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Andrew J Yee, Noopur S Raje
Panobinostat and Multiple Myeloma in 2018. The oncologist 23 (5) (2018)